Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort study
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort study
Authors
Keywords
-
Journal
ANNALS OF THE RHEUMATIC DISEASES
Volume 74, Issue 11, Pages 1968-1975
Publisher
BMJ
Online
2014-06-12
DOI
10.1136/annrheumdis-2014-205216
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development and Validation of an Administrative Case Definition for Inflammatory Bowel Diseases
- (2016) Ali Rezaie et al. CANADIAN JOURNAL OF GASTROENTEROLOGY
- Metabolic syndrome in rheumatoid arthritis: case control study
- (2013) Samira Rostom et al. BMC MUSCULOSKELETAL DISORDERS
- Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: a systematic review and meta-analysis
- (2013) P. Coto-Segura et al. BRITISH JOURNAL OF DERMATOLOGY
- Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study
- (2013) O. Ahlehoff et al. JOURNAL OF INTERNAL MEDICINE
- Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
- (2013) William B. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
- (2013) Benjamin M. Scirica et al. NEW ENGLAND JOURNAL OF MEDICINE
- Disease Activity in Inflammatory Bowel Disease Is Associated with Increased Risk of Myocardial Infarction, Stroke and Cardiovascular Death – A Danish Nationwide Cohort Study
- (2013) Søren Lund Kristensen et al. PLoS One
- DPP4 inhibitor-induced polyarthritis: a report of three cases
- (2013) Etienne Crickx et al. RHEUMATOLOGY INTERNATIONAL
- Peroxisome proliferator-activated receptor γ agonist effect on rheumatoid arthritis: a randomized controlled trial
- (2013) Michelle J Ormseth et al. ARTHRITIS RESEARCH & THERAPY
- 2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial
- (2012) Baptist Gallwitz et al. LANCET
- The incident user design in comparative effectiveness research
- (2012) Eric S. Johnson et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis
- (2012) K. P. Liao et al. RHEUMATOLOGY
- The effect of systemic psoriasis therapies on the incidence of myocardial infarction: a cohort study
- (2011) K. Abuabara et al. BRITISH JOURNAL OF DERMATOLOGY
- Sitagliptin, a Dipeptidyl Peptidase-IV Inhibitor, Improves Psoriasis
- (2011) Tatsuya Nishioka et al. DERMATOLOGY
- A combined comorbidity score predicted mortality in elderly patients better than existing scores
- (2011) Joshua J. Gagne et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Validation of rheumatoid arthritis diagnoses in health care utilization data
- (2011) Seo Young Kim et al. ARTHRITIS RESEARCH & THERAPY
- Treatment Effects in the Presence of Unmeasured Confounding: Dealing With Observations in the Tails of the Propensity Score Distribution--A Simulation Study
- (2010) T. Sturmer et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Is the incidence of rheumatoid arthritis rising?: Results from Olmsted County, Minnesota, 1955-2007
- (2010) Elena Myasoedova et al. ARTHRITIS AND RHEUMATISM
- Expression and functional role of 1F7 (CD26) antigen on peripheral blood and synovial fluid T cells in rheumatoid arthritis patients
- (2010) C. MUSCAT et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Thiazolidinedione use and ulcerative colitis-related flares: An exploratory analysis of administrative data
- (2010) Jennifer L. Lund et al. INFLAMMATORY BOWEL DISEASES
- Identification and validation of lupus nephritis cases using administrative data
- (2010) LB Chibnik et al. LUPUS
- Medical chart validation of an algorithm for identifying multiple sclerosis relapse in healthcare claims
- (2010) Benjamin J. Chastek et al. JOURNAL OF MEDICAL ECONOMICS
- Some Methods of Propensity-Score Matching had Superior Performance to Others: Results of an Empirical Investigation and Monte Carlo simulations
- (2009) Peter C. Austin BIOMETRICAL JOURNAL
- Decreased Expression of T Lymphocyte Co-Stimulatory Molecule CD26 on Invariant Natural Killer T Cells in Systemic Lupus Erythematosus
- (2009) P. T. Y. Wong et al. IMMUNOLOGICAL INVESTIGATIONS
- Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?
- (2009) Roger Yazbeck et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- CD26/dipeptidyl-peptidase IV in psoriatic skin: upregulation and topographical changes
- (2008) R.G. van Lingen et al. BRITISH JOURNAL OF DERMATOLOGY
- Inhibiting dipeptidyl peptidase activity partially ameliorates colitis in mice
- (2008) Roger Yazbeck Frontiers in Bioscience-Landmark
- Rosiglitazone for Active Ulcerative Colitis: A Randomized Placebo-Controlled Trial
- (2008) James D. Lewis et al. GASTROENTEROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started